4,4-Difluoro-1,2,3,4-tetrahydro-5H-1-be nzazepine derivatives or salts thereof

Details for Australian Patent Application No. 2002349773 (hide)

Owner Astellas Pharma Inc.

Inventors Akamatsu, Seijiro; Tsukamoto, Issei; Koshio, Hiroyuki; Saitoh, Chikashi; Kuramochi, Takahiro

Agent Davies Collison Cave

Pub. Number AU-B-2002349773

PCT Number PCT/JP02/11842

PCT Pub. Number WO2003/042181

Priority 2002-252931 30.08.02 JP; 2001-350909 16.11.01 JP

Filing date 13 November 2002

Wipo publication date 26 May 2003

Acceptance publication date 13 December 2007

International Classifications

C07D 223/16 (2006.01) Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

A61P 7/12 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 13/00 (2006.01) Drugs for disorders of the urinary system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

13 March 2003 Complete Application Filed

  Priority application(s): 2002-252931 30.08.02 JP; 2001-350909 16.11.01 JP

24 July 2003 Application Open to Public Inspection

  Published as AU-B-2002349773

22 December 2005 Assignment before Grant

  Yamanouchi Pharmaceuticals Co., Ltd. The application has been assigned to Astellas Pharma Inc.

13 December 2007 Application Accepted

  Published as AU-B-2002349773

10 April 2008 Standard Patent Sealed

10 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002349774-TRANSGENIC ANIMAL

2002349772-METHOD FOR DISSOLVING SATURATED POLYESTER, SOLUTION FOR DECOMPOSING SATURATED POLYESTER AND METHOD FOR DECOMPOSITION USING THE SAME